	coopervision eye delays annual meeting coopervision inc said it has delayed its annual meeting to june from may to allow its board to review possible recapitalization options before the meeting coopervision today reported first quarter net income of mln dlrs after a mln dlr pretax gain from the sale of its ophthalmic business to johnson and johnson jnj for mln dlrs in cash and a mln dlr posttax charge from a debt repurchase sales were mln dlrs a year earlier it ed dlrs after a dlr loss from discontinued operations on sales of mln dlrs the company said an aggressive program of investment spending to maintain or increase market shares its its two core businesses will accelerate sales growth this year but hold back increases in operating income in the near future coopervision said furthermore until the entire net cash proceeds from the recent sales of several of our businesses are employed to reduce indebtedness make strategic acquisitions and or are otherwise employed in relation to a possible recapitalization of the company recovery of net income will be held back by the loss particularly of the tax income of the ophthalmic pharmaceutical business sold to johnson and johnson reuter 
